Literature DB >> 9322687

Red cell aplasia caused by parvovirus B19 in AIDS: use of i.v. immunoglobulin.

P R Koduri1, R Kumapley, N D Khokha, A R Patel.   

Abstract

We describe the case of a 34-year-old man with AIDS who developed severe anemia due to chronic pure red cell aplasia (PRCA) caused by parvovirus B19. Following initial treatment with an infusion of intravenous immunoglobulin (IVIg), 1 g/kg, PRCA resolved, but there was a recurrence of severe anemia in 3 months. Retreatment with 2 g/kg IVIg over 2 days resulted in normalization of hemoglobin and a significantly longer remission duration. Two doses of 0.4 g/kg IVIg q 4 wk failed to prevent a relapse of PRCA in our patient. The dose and schedule of IVIg in the treatment of PRCA caused by parvovirus B19 in AIDS requires further definition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9322687     DOI: 10.1007/s002770050315

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

1.  Parvovirus infection-induced DNA damage response.

Authors:  Yong Luo; Jianming Qiu
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

4.  A Persistent Parvovirus Infection Causing Anemia in an HIV Patient Requiring Intravenous Immunoglobulin Maintenance Therapy.

Authors:  Dhairya Gor; Vinit Singh; Varsha Gupta; Michael Levitt
Journal:  Cureus       Date:  2022-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.